Estrogel
Payments companies reported to CMS as associated with Estrogel. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Estrogel, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Estrogel
These are the largest totals companies reported as associated with Estrogel. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Maureen Whelihan | Greenacres, FL | Obstetrics & Gynecology | $26,776.92 |
| Steven Rabin | Burbank, CA | Gynecology | $23,740.82 |
| Elliot Cazes | Tampa, FL | Obstetrics & Gynecology | $23,015.66 |
| James Simon | Washington, DC | Gynecology | $12,174.10 |
| A Staub | Dallas, TX | Obstetrics & Gynecology | $10,242.01 |
| John Paciuc | New York, NY | Obstetrics & Gynecology | $5,719.75 |
| Ricki Pollycove | San Francisco, CA | Gynecology | $3,148.89 |
| Maurice Leibman | Houston, TX | Gynecology | $3,067.93 |
| Parveen Vahora | New Port Richey, FL | Gynecology | $3,002.80 |
| Felice Gersh | Irvine, CA | Gynecology | $2,610.52 |
Prescribed Estrogel?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.